In the current study, we demonstrated that miR‐133b downregulated FOXL2 expression by targeting the 3′‐UTR of FOXL2 to inhibit cell proliferation, EMT, and metastasis induced by the TGF‐β/Smad signaling pathway in NSCLC. This evidence concerns the gene TGFB1 and non-small cell lung carcinoma.